Experiments directed towards identifying the mechanism by which another micro RNA, miR-129-5p, inhibits HCC growth have identified Ca2+/calmodulin-dependent protein kinase IV (CamKIV) as a potential therapeutic target [38]. Here, CAMK4 is linked to hepatocellular carcinoma.